PBMNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBMWW
PSYENCE BIOMEDICAL LTD.
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 22, 2026
$4.12−0.10 (-2.37%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0M
Shares held, 13F filers
Institutional holders
9
7 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Hudson Bay Capital Management LP | 380,000 | 9.98% | 13G (passive) | Dec 31, 2024 |
| Psyence Labs Ltd. | 2,643,659 | 49.75% | 13D (active) amendment | Oct 1, 2026 |
| AdvisorShares Trust | 258,538 | 6.78% | 13G (passive) | Sep 30, 2026 |
| Harraden Circle Investors GP, LLC | 182,323 | 5.32% | 13G (passive) amendment | Dec 31, 2024 |
| White Lion Capital, LLC | 100,000 | 8.93% | 13G (passive) | Dec 4, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PBM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Parallel Advisors, LLC | 151,250 | – | $574.75K | – | 0.01% |
| AdvisorShares Investments LLC | 122,184 | – | $373.88K | New | 0.05% |
| Morgan Stanley | 37,804 | – | $115.68K | New | 0.00% |
| Jane Street Group, LLC | 30,431 | – | $93.12K | New | 0.00% |
| XTX Topco Ltd | 15,094 | – | $46.19K | New | 0.00% |
| Citadel Advisors LLC | 11,693 | – | $35.78K | New | 0.00% |
| Stonehage Fleming Financial Services Holdings Ltd | 89 | – | $272 | – | 0.00% |
| UBS Group AG | 60 | – | $184 | New | 0.00% |
| Caitlin John, LLC | 35 | – | $107 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 9 | 0M | 7 / 0 | 0 / 0 | 0M | 0M |
| Q1 2026 | 2 | 0M | 1 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of PBM | Value | % of fund | As of |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF | 122,184 | – | $373.88K | 0.84% | Jun 30, 2026 |